Re:Goldman Sachs questions whether curing patients is a sust...
by mft_ on Friday April 13, 2018 @05:26AM
(#16828299)
Drug development is really hard - the odds are stacked against you.
Any successful drug with half a business case will be launched - no company can afford to be picky about cure vs. chronic treatment - there just aren't that many successful drug discoveries to enable it.
Any successful drug with half a business case will be launched - no company can afford to be picky about cure vs. chronic treatment - there just aren't that many successful drug discoveries to enable it.